Drug Shortage Report for MYLAN-NIFEDIPINE EXTENDED RELEASE

Last updated on 2020-01-09 History
Report ID 33010
Drug Identification Number 02321149
Brand name MYLAN-NIFEDIPINE EXTENDED RELEASE
Common or Proper name NIFEDIPINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) NIFEDIPINE
Strength(s) 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100 BT
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-10-15
Actual start date 2018-10-15
Estimated end date 2020-01-05
Actual end date 2020-01-08
Shortage status Resolved
Updated date 2020-01-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v115 2020-01-09 French Compare
v114 2020-01-09 English Compare
v113 2019-10-29 French Compare
v112 2019-10-29 English Compare
v111 2019-10-08 French Compare
v110 2019-10-08 English Compare
v109 2019-01-18 French Compare
v108 2019-01-18 English Compare
v107 2019-01-08 French Compare
v106 2019-01-08 English Compare
v105 2018-12-19 French Compare
v104 2018-12-19 English Compare
v103 2018-11-20 French Compare
v102 2018-11-20 English Compare
v101 2018-11-13 French Compare
v100 2018-11-13 English Compare
v99 2018-10-16 French Compare
v98 2018-10-16 English Compare
v97 2018-10-11 English Compare
v96 2018-10-09 French Compare

Showing 1 to 20 of 115